Malignant neoplasm of frontal lobe
Study comparing conventional radiotherapy vs stereotactic radiotherapy in GBM
Who can joinAsk the trial team
AgeAsk the trial team
Kind of studyPhase 2: does it work?
What it testsA medicine and radiation
The full list of who can and cannot join is on the registry. Ask the trial team, or write to us and we will explain it in simple words.
Contact hospital
The registry names this hospital as the trial's main contact. Ask them which hospitals are taking patients.
All India Institute of Medical SciencesIndiaDirections ↗
Registry summary (technical)
A phase II randomized controlled study comparing post-operative stereotactic radiotherapy versus conventional radiotherapy along with concurrent and adjuvant temozolomide in patients with de novo glioblastoma - NIL
Sponsor: AIIMS, New Delhi
CTRI/2024/11/076832 on CTRI, India's trial registry
Source: Clinical Trials Registry – India (CTRI), via WHO ICTRP, data of 12 Oct 2026
Last updated on the registry 14 Sep 2026 · read by us 5 Nov 2026